A Company Advertised a Pain Relief Ointment Called "Aspercreme

Multiple Choice

A company advertised a pain relief ointment called "Aspercreme." The package stated "the strong relief of aspirin right where you hurt." The product did not contain any aspirin.The FTC ruled that:

A) the advertising was not deceptive since the benefit of the product outweighed any harm caused by potentially misleading claims.
B) the advertising was misleading, and the company would have to change the name of the product or add aspirin to its formula.
C) the advertising was deceptive, and the FTC required the company to specifically state in its promotions that the product did not contain aspirin.
D) None of the above